• Homepage
  • Beyond the Proof-of-Concept: How mRNA Manufacturers Disrupt the Industry

Apply a Template Approach to mRNA Production for a Robust and Flexible Process

Are you ready for the mRNA revolution? Learn how biopharmaceutical companies can apply proven strategies to overcome the hidden complexities in mRNA production. Discover solutions that can help you rapidly design and build a SU facility for all aspects of mRNA manufacturing.
 

Watch Online

What Will You Learn:
  1. Key trends and challenges in mRNA development and manufacturing.
  2. How Sartorius technology and expertise can help with all steps of mRNA production.
  3. Strategies and solutions for rapidly designing and building a SU mRNA facility.

Meet Our Experts:

Ganesh Kumar

MS, Integrated Solutions Manager, Sartorius

Ganesh started at Sartorius in 2016 as a Process Engineer | Consultant and was one of the key contributors to the development of the conceptual design platform to design end-to-end process platforms in SU facilities. Today he fills the role of Integrated Solutions Manager. As part of the Integrated Solutions team at Sartorius,

he actively works with clients to conceptualize, design, and deliver process solutions and platforms at clinical | commercial manufacturing stage for production of protein-based and cell | gene-based therapies. He holds a Master of Science in Bioprocess Engineering from Technical University Hamburg-Harburg, Germany. Ganesh started his career at Lonza, Singapore, where he was actively involved in the tech transfer, validation, and large-scale commercial manufacturing of blockbuster mAbs. Over the years, he has actively collaborated|led projects on process positioning, acquisitions, building the technical platform, solution packages and establishing strategic customer collaborations for process intensification. He has over nine years of experience in the biopharmaceutical industry, both as an end-user and a solution provider. He is based in Göttingen, Germany.

Nargisse El Hajjami

Process Technology Manager mRNA

Nargisse El Hajjami joined Sartorius in 2022 as Global mRNA Process Technology Manager. She holds a master’s degree in biotechnology and bioengineering and a PhD in biomedical and pharmaceutical sciences from the Université libre de Bruxelles in Brussels, Belgium. She has 12 years’ experience combining scientific research, process development, biomanufacturing engineering, and business development.

Complete Form to Watch Online